The content must not be changed in any way or reproduced in any format or medium without the formal permission of the copyright holder(s) When referring to this work, full bibliographic details must be given. Determination of personal health status based on a biomarker of ageing and not as a direct function of chronology requires very sensitive and specific biomarkers. Validated markers of biological age are few and must meet the Baker and Sprott criterion-"A biomarker of ageing is a biological parameter of an organism that either alone or in some multivariate composite will, in the absence of disease, better predict functional capability at some late age, than will chronological age."
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Although many biomarkers have been tested, only two fulfil this criterion-CDKN2A and telomere length. CDKN2A has been tested only in small independent studies and rarely in combination with telomere length. In these, telomere length has proved to be a significantly weaker biomarker. CDKN2A has also proved to be superior to chronological age. 3 4 Inter-individual variation in telomere length is subject to numerous socioeconomic and lifestyle confounders. This makes it very unreliable in individuals. 5 6 From this standpoint, using telomere length commercially to determine individual health status seems premature.
A knowledge of telomere length as a read-out of health is, however, still very relevant, but only in the context of larger clinical investigations and population or public health studies, where socioeconomic, lifestyle, and epigenetic confounders are taken into account. 6 It remains to be determined how relevant CDKN2A expression will prove to be as a measure of personal and public health.
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